Home / Blog

February 24, 2024

Harness the healing potential of nature’s pharmacy as we shine a spotlight on antiviral herbs and explore their time-tested efficacy and immune-empowering effects.

You can also watch this video on Rumbl here.

ECHINACEA (Echinacea purpurea) – Widely believed to have antiviral activity and the potential to boost immune function. 

  • Randomized Controlled Trial (RCT) on Cold Prevention:

 A randomized, double-blind, placebo-controlled study published in the journal “Evidence-Based Complementary and Alternative Medicine” in 2012 found that Echinacea supplements reduced the risk of developing the common cold by 58%. The study concluded that Echinacea could be a useful preventive strategy against viral respiratory infections.

  • Meta-analysis on Echinacea for Upper Respiratory Infections:

A meta-analysis published in the “Lancet Infectious Diseases” in 2007 reviewed several trials and suggested that Echinacea preparations might reduce the risk of recurrent upper respiratory infections and decrease the duration of cold symptoms.

  • Echinacea purpurea Extract and Influenza Virus:

A study published in the journal “Virology Journal” in 2009 investigated the effects of Echinacea purpurea extract on influenza A virus. The study found that the extract inhibited viral replication in vitro and suggested that Echinacea may have potential in influenza treatment.

  • Echinacea Alkamides and Rhinovirus Infection:

Research published in “Planta Medica” in 2015 explored the effects of Echinacea alkamides on rhinovirus infection, a common cause of the common cold. The study suggested that Echinacea alkamides could reduce virus-induced inflammation and improve antiviral defenses.

TURMERIC (Curcuma longa) – Curcumin, the active compound in turmeric, is known for its anti-inflammatory and antioxidant properties, and it may have antiviral activity.

  • Inhibition of Hepatitis B Virus (HBV):

A study published in the journal “Antiviral Research” in 2013 found that curcumin, the active compound in turmeric, could inhibit the replication of hepatitis B virus in vitro. The study suggested that curcumin might be explored as a potential therapeutic agent against HBV.

  • Antiviral Effects on Herpes Simplex Virus (HSV):

Research published in the “Journal of Natural Products” in 2012 investigated the antiviral activity of curcumin and its derivatives against herpes simplex virus type 1 (HSV-1). The study found that certain curcumin derivatives had potent antiviral effects against HSV-

  • Antiviral Potential Against Zika Virus:

A study published in the journal “Scientific Reports” in 2017 explored the effects of curcumin on the Zika virus. The research indicated that curcumin could inhibit Zika virus replication in vitro, suggesting a potential role in antiviral therapy.

  • Antiviral Effects Against Influenza A Virus:

A study published in the “Journal of General Virology” in 2011 investigated the antiviral activity of curcumin against the influenza A virus. The research found that curcumin inhibited the replication of the virus and reduced virus-induced lung inflammation in mice. This suggests that curcumin may have potential as a natural antiviral agent against influenza A infections.

  • Antiviral Activity Against HIV-1:

Research published in “Biochemical and Biophysical Research Communications” in 2005 examined the impact of curcumin on the human immunodeficiency virus type 1 (HIV-1). The study indicated that curcumin could inhibit the activation of HIV-1 in cultured cells. While this suggests a potential role in HIV treatment, further research is needed to determine its clinical relevance.

ASTRAGALUS (Astragalus membranaceus) – Known for its immune-modulating properties, astragalus may help support the immune system in fighting viral infections.

  • Immune Enhancement Against Respiratory Viruses:

A study published in the “Journal of Ethnopharmacology” in 2013 explored the effects of Astragalus membranaceus extract on immune responses to respiratory viruses. The research suggested that the extract could enhance the immune system’s ability to respond to viral infections, potentially reducing the severity and duration of symptoms.

  • Antiviral Activity Against Herpes Simplex Virus (HSV):

A study published in the “Journal of Virology” in 2004 investigated the antiviral activity of an astragalus polysaccharide against herpes simplex virus type 1 (HSV-1). The research found that the polysaccharide inhibited the replication of HSV-1 and suggested its potential as an antiviral agent.

  • Antiviral Effects on Coxsackievirus B3 (CVB3):

Research published in “Antiviral Research” in 2011 explored the effects of an astragalus polysaccharide on Coxsackievirus B3 (CVB3), a virus associated with myocarditis. The study suggested that the polysaccharide had antiviral activity against CVB3 and reduced viral replication. Research published in “Journal of Medical Virology” in 2014 investigated the impact of an Astragalus membranaceus extract on respiratory syncytial virus (RSV) infection. The study found that the extract exhibited significant antiviral activity against RSV, potentially reducing viral replication and the severity of RSV-induced lung inflammation.

  • Inhibition of Influenza A Virus Replication:

A study published in “Virus Research” in 2010 explored the effects of Astragalus polysaccharides on the replication of influenza A virus (IAV). The research indicated that the polysaccharides inhibited IAV replication by interfering with viral RNA synthesis. This suggests that Astragalus may have potential as an antiviral agent against influenza.

CAT’S CLAW  (Uncaria tomentosa) – Believed to have immune-stimulating properties and antiviral effects.

  • Antiviral Effects Against Herpes Simplex Virus (HSV):

A study published in the “Journal of Ethnopharmacology” in 2001 investigated the antiviral activity of cat’s claw extract against herpes simplex virus type 1 (HSV-1). The study suggested that cat’s claw may have the potential to inhibit HSV-1 replication in vitro, particularly when used in combination with other antiviral agents.

  • Cat’s Claw Extract and Inhibition of HSV-1:

A study published in “Phytotherapy Research” in 2010 investigated the effect of cat’s claw extract on herpes simplex virus type 1 (HSV-1) infection. The research suggested that cat’s claw extract inhibited HSV-1 replication in a laboratory setting.

  • Antiviral Activity Against Human Immunodeficiency Virus (HIV):

A study published in the “Journal of Acquired Immune Deficiency Syndromes” in 2003 explored the potential anti-HIV effects of cat’s claw extract. While the study did not focus on direct antiviral activity, it suggested that cat’s claw may have immunomodulatory effects that could be relevant in HIV therapy.

  • Cat’s Claw and Influenza Virus (IAV):

A study published in the “Journal of Medicinal Food” in 2017 investigated the effects of cat’s claw extract on influenza A virus (IAV). The research found that cat’s claw demonstrated some inhibitory activity against IAV in cell cultures.

CHAPARRAL (Larrea tridentata) – Believed to have antiviral, antibacterial and anti-inflammatory properties. 

  • Antiviral Activity Against Herpes Simplex Virus (HSV):

A study published in the “Journal of Ethnopharmacology” in 2004 investigated the antiviral activity of Larrea tridentata against herpes simplex virus (HSV). The researchers found that extracts from Chaparral exhibited inhibitory effects on HSV-1 and HSV-2 in laboratory experiments. The study suggested that Chaparral may have potential as a natural antiviral agent against herpes viruses.

  • Inhibition of Respiratory Syncytial Virus (RSV):

Another study, published in the “Journal of Medical Virology” in 2009, explored the inhibitory effects of Larrea tridentata on respiratory syncytial virus (RSV). The researchers observed that Chaparral extracts demonstrated antiviral activity against RSV in vitro. However, the study emphasized the need for further research to explore the underlying mechanisms and evaluate the safety and efficacy of Chaparral for antiviral purposes.

  • Antiviral Potential Against Influenza A Virus:

A study in the “Journal of Ethnopharmacology” in 2018 investigated the antiviral potential of Larrea tridentata against influenza A virus. The findings suggested that Chaparral extracts exhibited inhibitory effects on the replication of influenza A virus in cell cultures. The study highlighted the need for additional research to assess the safety and efficacy of Chaparral as a potential antiviral agent.

Here are our top antiviral Barlow Herbal product suggestions

    Note: Please keep in mind that this blog post is for research and educational purposes only. This information and any products mentioned have not been approved by the FDA. None of this information is meant to diagnose, treat or cure any disease. It is essential to consult a qualified healthcare professional before adding any herbal supplements to your diet or regimen.